Nepal govt to get 4 million Moderna Covid-19 vaccines under GAVI

The Nepal government on Friday signed a deal with GAVI, the Vaccine Alliance, to procure 4 million doses of the Moderna coronavirus vaccine.

Moderna Covid-19 vaccine
Press Trust of India Kathmandu
2 min read Last Updated : Aug 13 2021 | 10:03 PM IST

The Nepal government on Friday signed a deal with GAVI, the Vaccine Alliance, to procure 4 million doses of the Moderna coronavirus vaccine.

The vaccine will be imported under the World Bank's financing, according to a press statement by World Bank, Nepal office.

Nepal is the second country globally to have completed agreements with GAVI to procure 4 million doses of Moderna vaccines, under the World Bank financing, through the COVAX cost-share option," the statement read.

Gavi is a global, publicprivate health partnership.

"Nepal is an early mover in utilising the COVAX cost-share scheme, and I am pleased to note that we have finalised an arrangement, despite challenging circumstances, to bring safe and highly effective vaccines to Nepal," said Health Minister Umesh Shrestha.

"Moderna vaccines have helped expand options for vaccination among Nepalis above 12 years of age and fast-track Nepal's progress towards a safer post-COVID world," he said.

"Delivery of these vaccines is expected to start by March 2022 and will contribute to Nepal's goal to vaccinate at least 72 per cent of its population, as well as children 12 to 17 years of age for whom the Moderna vaccine is deemed safe and effective," the World Bank said in a statement.

Meanwhile, Nepal reported 3,915 fresh COVID-19 cases in the last 24 hours, taking the country's case load to 800,256, the Health Ministry said.

The death rose to 10,239 after 27 COVID-related deaths were reported in the same period. Currently, Nepal has 38,798 active COVID-19 cases.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus VaccineNepal

First Published: Aug 13 2021 | 10:03 PM IST

Next Story